TRANSITION TIMES

RK

Richard Kender

Executive Chair and Interim CEO @ Seres Therapeutics

Richard Kender has over 35 years of experience in the biopharmaceutical industry, including a significant tenure at Merck & Co.

1
Mentions
First mentioned:
Mar 2026
Last mentioned:
Mar 2026

Career Trajectory